Expression of the c-myc proto-oncogene is essential for HIV-1 infection in activated T cells

Journal of Experimental Medicine

Volumn 189, Issue 9, 1999, Pages 1391-1397

  Sun, Yu ^a   Clark, Edward A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Apoptosis; C Myc; HIV 1 DNA; Nuclear import; T cell

Indexed keywords

CD4 ANTIGEN; T LYMPHOCYTE RECEPTOR; VIRUS DNA;

APOPTOSIS; ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS INFECTION;

CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DNA, VIRAL; GENE EXPRESSION; HIV-1; HUMANS; LYMPHOCYTE ACTIVATION; PROTO-ONCOGENE PROTEINS C-MYC;

EID: 0033519284     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.9.1391     Document Type: Article

References (66)

1. Dalgleish, A.C., P.C. Beverley, P.R. Clapham, D.H. Crawford, M.F. Greaves, and R.A. Weiss. 1984. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature. 312:763-767.
2. Deng, H.K., D. Unutmaz, V.N. KewalRamani, and D.R. Littman. 1997. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature. 388: 296-300.
3. Doranz, B.J., J. Rucker, Y. Yi, R.J. Smyth, M. Samson, S.C. Peiper, M. Parmentier, R.G. Collman, and R.W. Doms. 1996. A dual-tropic primary HIV-1 isolate that uses fusin and the beca-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell. 85:1149-1158.
4. Dragic, T., V. Litwin, G.P. Allaway, S.R. Martin, Y. Huang, K.A. Nagashima, C. Cayanan, P.J. Maddon, R.A. Koup, J.P. Moore, and W.A. Paxton. 1996. HIV-1 entry into CD4 + cells is mediated by the chemokine receptor CC-CKR-5. Nature. 381:667-673.
5. Bukrinsky, M.I., N. Sharova, T.L. McDonald, T. Pushkarskaya, W.G. Tarpley, and M. Stevenson. 1993. Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Prof. Natl. Acad. Sci. USA. 90:6125-6129.
6. Farnet, C.M., and W.A. Haseltine. 1991. Circularization of human immunodeficiency virus type 1 DNA in vitro. J. Virol. 65:6942-6952.
7. Farnet, C.M., and F.D. Bushman. 1996. HIV cDNA integration: molecular biology and inhibitor development. AIDS. 10:S3-S11.
8. Meyaard, L., S.A. Otto, R.R. Jonker, M.J. Mijnster, R.P. Keet, and F. Miedema. 1992. Programmed death of T cells in HIV-1 infection. Science. 257:217-219.
9. Terai, C., R.S. Kornbluth, C.D. Pauza, D.D. Richman, and D. A. Carson. 1991. Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. J. Clin. Invest. 87:1710-1715.
10. Stevenson, M., T.L. Stanwick, M.P. Dempsey, and C.A. Lamonica. 1990. HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO (Eur. Mol. Biol. Organ.) J. 9:1551-1560.
11. Zack J.A., S.J. Arrigo, S.R. Weitsman, A.S. Go, A. Haislip, and I.S. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell. 61:213-222.
12. Bukrinsky, M.I., T.L. Stanwick, M.P. Dempsey, and M. Stevenson. 1991. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science. 254:423-427.
13. Spina, C.A., J.C. Guatelli, and D.D. Richman. 1995. Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro. J. Virol. 69:2977-2988.
14. + T cells requires a cyclosporin A-sensitive pathway. J. Immunol. 158: 512-517.
15. Chun, T.W., L. Carruth, D. Finzi, X. Shen, J.A. DiGiuseppe, H. Taylor, M. Hermankova, K. Chadwick, J. Margolick, T.C. Quinn, et al. 1997. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature. 387:183-188.
16. - resting T cells cannot be infected de novo with HIV-1. Proc. Natl. Acad. Sci. USA. 94:1361-1365.
17. Polacino, P.S., H.A. Liang, and E.A. Clark. 1995. Formation of simian immunodeficiency virus long terminal repeat circles in resting T cells requires both T cell receptor- and IL-2-dependent activation. J. Exp. Med. 182:617-621.
18. Polacino, P.S., L.M. Pinchuk, S.P. Sidorenko, and E.A. Clark. 1996. Immunodeficiency virus cDNA synthesis in resting T lymphocytes is regulated by T cell activation signals and dendritic cells. J. Med. Primatol. 25:201-209.
19. Heikkila, R., G. Schwab, E. Wickstrom, S.L. Loke, D.H. Pluznik, R. Watt, and L.M. Neckers. 1987. A c-myc anti-sense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1. Nature. 328:445-449.
20. Bazar, L., V. Harris, I. Sunitha, D. Hartmann, and M. Avigan. 1995. A transactivator of c-myc is coordinately regulated with the proto-oncogene during cellular growth. Oncogene. 10:2229-2238.
21. Grandori, C., and R.N. Eisenman. 1997. Myc target genes. Trends. Biochem. Sci. 22:177-181.
22. Potter, M., and K.B. Marcu. 1997. The c-myc story: where we've been, where we seem to be going. Curr. Top. Microbiol. Immunol. 224:1-17.
23. Shi, Y., J.M. Glynn, L.J. Guilbert, T.G. Cotter, R.P. Bissonnette, and D.R. Green. 1992. Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science. 257:212-214.
24. Vastrik, I., T.P. Makela, P.J. Koskinen, J. Klefstrom, and K. Alitalo. 1994. Myc protein: partners and antagonists. Crit. Rev. Oncog. 5:59-68.
25. Kim, Y.H., M.A. Buchholz, F.J. Chrest, and A.A. Nordin. 1994. Up-regulation of c-myc induces the gene expression of the murine homologues of p34cdc2 and cyclin-dependent kinase-2 in T lymphocytes. J. Immunol. 152:4328-4335.
26. Kawahara, A., Y. Minami, T. Miyazaki, J.N. Ihle, and T. Taniguchi. 1995. Critical role of the interleukin 2 (IL-2) receptor gamma-chain-associated Jak3 in the IL-2-induced c-fos and c-myc, but not bcl-2, gene induction. Proc. Natl. Acad. Sci. USA. 92:8724-8728.
27. Minami, Y., Y. Nakagawa, A. Kawahara, T. Miyazaki, K. Sada, H. Yamamura, and T. Taniguchi. 1995. Protein tyrosine kinase Syk is associated with and activated by the IL-2 receptor: possible link with the c-myc induction pathway. Immunity. 2:89-100.
28. Miyazaki, T., Z.J. Liu, A. Kawahara, Y. Minami, K. Yamada, Y. Tsujimoto, E.L. Barsoumian, R.M. Permutter, and T. Taniguchi. 1995. Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation. Cell. 81:223-231.
29. Shibuya, H., M. Yoneyama, T.-J. Ninomiya, K. Matsumoto, and T. Taniguchi. 1992. IL-2 and EGF receptors stimulate the hematopoietic cell cycle via different signaling pathways: demonstration of a novel role for c-myc. Cell. 70:57-67.
30. Takeshita, T., T. Arita, M. Higuchi, H. Asao, K. Endo, H. Kuroda, N. Tanaka, K. Murata, N. Ishii, and K. Sugamura. 1997. STAM, signal transducing adaptor molecule, is associated with Janus kinases and involved in signaling for cell growth and c-myc induction. Immunity. 6:449-457.
31. Natazuka, T., O.-T. Umemiya, T. Matsui, T. Saida, and Y. Nakao. 1993. FK506 and cyclosporin A regulate proliferation and proto-oncogene expression in HTLV-1-associated myelopathy/tropical-spastic-paraparesis-derived T cells. Int. J. Cancer. 54:348-354.
32. Ginobbi, P., T.A. Geiser, D. Ombres, and G. Citro. 1997. Folic acid-polylysine carrier improves efficacy of c-myc anti-sense oligodeoxynucleotides on human melanoma (M 14) cells. Anticancer Res. 17:29-36.
33. Pinchuk, L.M., P.S. Polacino, M.B. Agy, S.J. Klaus, and E.A. Clark. 1994. The role of CD40 and CD80 accessory cell molecules in dendritic cell-dependent HIV-1 infection. Immunity. 1:317-325.
34. Polacino, P.S., H.A. Liang, E.J. Firpo, and E.A. Clark. 1993. T-cell activation influences initial DNA synthesis of simian immunodeficiency virus in resting T lymphocytes from macaques. J. Vitol. 67:7008-7016.
35. Majumdar, C., J. Abbotts, S. Broder, and S.H. Wilson. 1988. Studies on the mechanism of human immunodeficiency virus reverse transcriptase. Steady-state kinetics, processivity, and polynucleotide inhibition. J. Biol. Chem. 263:15657-15665.
36. Majumdar, C., C.A. Stein, J.S. Cohen, S. Broder, and S.H. Wilson. 1989. Stepwise mechanism of HIV reverse transcriptase: primer function of phosphorothioate oligodeoxy-nucleotide. Biochemistry. 28:1340-1346.
37. Matsukura, M., K. Shinozuka, G. Zon, H. Mitsuya, M. Reitz, J.S. Cohen, and S. Broder. 1987. Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA. 84:7706-7710.
38. Balotta, C., P. Lusso, R. Crowley, R.C. Gallo, and G. Franchini. 1993. Antisense phosphorothioate oligodeoxynu-cleotides targeted to the vpr gene inhibit human immunodeficiency virus type 1 replication in primary human macrophages. J Virol. 67:4409-4414.
39. Evan, G.I., G.K. Lewis, G. Ramsay, and M.J. Bishop. 1985. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol. Cell. Biol. 5:3610-3616.
40. Hann, S.R., and R.N. Eisenman. 1984. Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells. Mol. Cell Biol. 4:2486-2497.
41. Morgan, J.H., and J.T. Parsons. 1986. Characterization of c-myc proteins from avian bursal lymphoma cell lines. Virology. 150:178-186.
42. Hann, S.R., M.W. King, D.L. Bentley, C.W. Anderson, and R.N. Eisenman. 1988. A non-AUG translational initiation in c-Myc exon 1 generates an N-terminally distinct protein whose synthesis is disrupted in Burkitt's lymphomas. Cell. 52: 185-195.
43. Luscher, B., and R.N. Eisenman. 1988. c-myc and c-myb protein degradation: effect of metabolic inhibitors and heat shock. Mol. Cell. Biol. 8:2504-2512.
44. Spotts, G.D., and S.R. Hann. 1990. Enhanced translation and increased turnover of c-niyc proteins occur during differentiation of murine erythroleukemia cells. Mol. Cell. Biol. 10: 3952-3964.
45. Spotts, G.D., S.V. Patel, Q.R. Xiao, and S.R. Hann. 1997. Identification of downstream-initiated c-Myc proteins which are dominant-negative inhibitors of transactivation by fulllength c-Myc proteins. Mol. Cell. Biol. 17:1459-1468.
46. Kretzner, L., E.M. Blackwood, and R.N. Eisenman. 1992. Myc and Max proteins possess distinct transcriptional activities. Nature. 359:426-429.
47. Gupta, S., A. Seth, and R.J. Davis. 1993. Transactivation of gene expression by Myc is inhibited by mutation at the phosphorylation sites Thr-58 and Ser-62. Proc. Natl. Acad. Sci. USA. 90:3216-3220.
48. Henriksson, M., A. Bakardjiev, G. Klein, and B. Luscher. 1993. Phosphorylation sites mapping in the N-terminal domain of c-myc modulate its transforming potential. Oncogene. 8:3199-3209.
49. Xiao, Q.R., G. Claassen, J.Y. Shi, S. Adachi, J. Sedivy, and S.R. Hann. 1998. Transactivation-defective c-MycS retains the ability to regulate proliferation and apoptosis. Genes Dev. 12:3803-3808.
50. Weinberg, J.B., T.J. Mattews, B.R. Cullen, and M.H. Malim. 1991. Productive human immunodeficiency virus type-1 (HIV-1) infection of nonproliferating human monocytes. J. Exp. Med. 174:1477-1482.
51. Lewis, P., M. Hensel, and M. Emerman. 1992. Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO (Eur. Mol. Biol. Organ.) J. 11:3053-3058.
52. Bukrinsky, M.I., S. Haggerty, M.P. Dempsey, N. Sharova, A. Adzhubel, L. Spitz, P. Lewis, P. Goldfarb, M. Emerman, and M. Stevenson. 1993. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature. 365:666-669.
53. Heinzinger, N.K., M.I. Bukrinsky, S.A Haggerty, A.M. Ragland, V. Kewalramani, M.A. Lee, H.E. Genedlman, L. Ratner, and M. Stevenson. 1994. The Vpr protein of human immunodeficiency virus type-1 influences nuclear localization of viral nucleic acids in nondividing host cells. Prof. Natl. Acad. Sci. USA. 91:7311-7315.
54. Patterson, S., J. Gross, N. English, A. Stachpoole, P. Bedford, and S.C. Knight. 1995. CD4 expression on dendritic cells and their infection by human immunodeficiency virus. J. Gen. Virol. 76:1155-1163.
55. Lewis, P.F., and M. Emerman. 1994. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J. Virol. 68:510-516.
56. Popov, S., M. Rexach, G. Zybarth, N. Reiling, M.A. Lee, L. Ratner, C.M. Lane, M.S. Moore, G. Blobel, and M. Bukrinsky. 1998. Viral protein R regulates nuclear import of the HIV-1 pre-integration complex. EMBO (Eur. Mol. Biol. Organ.) J. 17:909-917.
57. Vodicka, M.A., D.M. Koepp, P.A. Silver, and M. Emerman. 1998. HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection. Genes Dev. 12:175-185.
58. Gallay, P., V. Stitt, C. Mundy, M. Oettinger, and D. Trono. 1996. Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import. J. Virol. 70:1027-1032.
59. Gallay, P., T. Hope, D. Chin, and D. Trono. 1997. HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway. Proc. Natl. Acad. Sci. USA. 94:9825-9830.
60. Bukrinsky, M., and O.K. Haffar. 1998. HIV-1 nuclear import: matrix protein is back on center stage, this time together with Vpr. Med. Med. 4:138-143.
61. Gulizia, J., M.P. Dempsey, N. Sharova, M.I. Bukrinsky, L. Spitz, D. Goldfarb, and M. Stevenson. 1994. Reduced nuclear import of human immunodeficiency virus type 1 preintegration complexes in the presence of a prototypic nuclear targeting signal. J. Virol. 68:2021-2025.
62. Bukrinsky, M.I., N. Sharova, M.P. Dempsey, T.L. Stanwick, A.G. Bukrinskaya, S. Haggerty, and M. Stevenson. 1992. Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc. Natl. Acad. Sci. USA. 89:6580-6584.
63. Gallay, P., S. Swingler, C. Aiken, and D. Trono. 1995. HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator. Cell. 80: 379-388.
64. Gallay, P., S. Swingler, J.P. Song, F. Bushman, and D. Trono. 1995. HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell. 83:569-576.
65. Bukrinskaya, A.G., A. Ghorpade, N.K. Heinzinger, T.E. Smithgall, R.E. Lewis, and M. Stevenson. 1996. Phosphorylation-dependent human immunodeficiency virus type-1 infection and nuclear targeting of viral DNA. Proc. Natl. Acad. Sci. USA. 93:367-371.
66. Jacque, J.M., A. Mann, H. Enslen, N. Sharova, B. Brichacek, R.J. Davis, and M. Stevenson. 1998. Modulation of HIV-1 infectivity by MAPK, a virion-associated kinase. EMBO (Eur. Mol. Biol Organ.) J. 17:2607-2618.